Just a few days ago there was a media article posted on here where the firms were claiming "strong interest' in the class action.
Now I see the figure is 1,900 shareholders. For perspective:
1,900 would equate to 1.8% of the shareholder register as at the end of the last financial year. I don't know, it doesn't look that strong at all to me.
Especially as this number would decrease once the eligibility of claimants is validated etc.
Looking back, from what I can see the class action against Bellamy's had two firms, one with ~1,500 and another with ~1,000, so ~2,500 people in total, and this for a much smaller market cap company.
In the A2M case there was a motion to grant a permanent stay on either of the class actions (Shine or SGH) just like in the Bellamy's case. Except for Bellamy's both actions were allowed to proceed alongside one another, meaning there would have been a clear precedent for two actions to proceed here with A2M as well.
So the only reason I could think of for them to consolidate here is that a) the size of the classes were not large enough to be worthwhile on their own, or b) A2M had a strong enough case that there was a real risk that the stay would be granted. Would be interested to see more detail of what went on (don't have access to the full text article).
- Forums
- ASX - By Stock
- A2M
- Slater and Gordon slaps class action on a2 Milk
A2M
the a2 milk company limited
Add to My Watchlist
1.67%
!
$7.93

Slater and Gordon slaps class action on a2 Milk, page-67
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B |
Open | High | Low | Value | Volume |
$7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.96 | 3799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 7.710 |
4 | 5739 | 7.700 |
1 | 64 | 7.680 |
3 | 2750 | 7.670 |
1 | 500 | 7.660 |
Price($) | Vol. | No. |
---|---|---|
7.960 | 565 | 1 |
7.990 | 8000 | 1 |
8.000 | 6318 | 7 |
8.010 | 6039 | 2 |
8.020 | 3294 | 2 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online